A three-factor preoperative scoring model predicts risk of recurrence after liver resection or transplantation in hepatocellular carcinoma patients with preserved liver function-Reference-Cited by-同舟云学术

A three-factor preoperative scoring model predicts risk of recurrence after liver resection or transplantation in hepatocellular carcinoma patients with preserved liver function

Published:2015-10 Issue:5 Volume:14 Page:477-484
ISSN:1499-3872
Container-title:Hepatobiliary & Pancreatic Diseases International
language:en
Short-container-title:Hepatobiliary & Pancreatic Diseases International

Author:

Li Yang,Ruan Dan-Yun,Yi Hui-Min,Wang Guo-Ying,Yang Yang,Jiang Nan

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference38 articles.

1. Global cancer statistics;Jemal;CA Cancer J Clin,2011

2. Resection and liver transplantation for hepatocellular carcinoma;Llovet;Semin Liver Dis,2005

3. Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma;Bruix;Hepatology,2005

4. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy;Imamura;J Hepatol,2003

5. Prospective validation of the Barcelona Clinic Liver Cancer staging system;Cillo;J Hepatol,2006

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An exploratory study:Cadonilimab(AK104) and Lenvatinib combined with stereotactic body radiotherapy in the conversion therapy of potentially resectable hepatocellular carcinoma;2024-06-11

2. Changes of long-term survival of resection and liver transplantation in hepatocellular carcinoma throughout the years: A meta-analysis;European Journal of Surgical Oncology;2024-03

3. The AGH score is a predictor of disease-free survival and targeted therapy efficacy after liver transplantation in patients with hepatocellular carcinoma;Hepatobiliary & Pancreatic Diseases International;2022-04

4. Neoadjuvant Approaches in Hepatocellular Carcinoma: There's No Time Like the Present;Clinical Cancer Research;2022-03-10

5. Evaluation of the Alpha-Fetoprotein Model for Predicting Recurrence and Survival in Patients With Hepatitis B Virus (HBV)–Related Cirrhosis Who Received Liver Transplantation for Hepatocellular Carcinoma;Frontiers in Surgery;2020-08-21